|
US2016109471A1
|
|
Lipoprotein particle number from measurements of lipoprotein particle phospholipid concentration in lipoprotein particle membrane bilayer
|
|
US2016109472A1
|
|
Quantitative molar concentration detection of specific apolipoprotein-containing particles present in bodily fluids by using capillary electrophoresis
|
|
US2016018422A1
|
|
Fatty acid pattern analysis for predicting acute coranary syndrome
|
|
US2015178466A1
|
|
Methods for aggregate reporting of health data and devices thereof
|
|
CN105849488A
|
|
Laboratory consumable drying device
|
|
US2015108076A1
|
|
Test tube rack insert device
|
|
US2015095058A1
|
|
Methods for laboratory sample tracking and devices thereof
|
|
US2015095057A1
|
|
Methods of initiating a workflow and devices thereof
|
|
WO2015021413A2
|
|
Applicator comb for gel electrophoresis
|
|
EP3022559A2
|
|
Method of determination of risk of 2 hour blood glucose equal to or greater than 140 mg/di
|
|
CN105209186A
|
|
Pipette tip washing device
|
|
US2014274891A1
|
|
Method of generating an index score for mbl deficiency to predict cardiodiabetes risk
|
|
US2015260631A1
|
|
System and method for assessing quanitites or sizes of lipoprotein particles from lipoprotein particle compositions
|
|
US2014272971A1
|
|
Unheated extraction of genomic dna in an automated laboratory system
|
|
WO2014160431A1
|
|
Method of determining prior history of ischemic stroke for current risk evaluation and therapy guidance
|
|
US2014095193A1
|
|
System and method for automatically generating a historical health trend graph for a patient
|
|
US2014324460A1
|
|
Method for determining and managing total cardiodiabetes risk
|
|
EP2877846A1
|
|
Compsition and method for gel electrophoresis with in-situ clalibration
|
|
US2013316926A1
|
|
Method for the monitoring of smoking cessation compliance and recovery, therapeutic intervention, and risk management
|
|
CA2874738A1
|
|
Process and apparatus for rapid, high-throughput analysis of fatty acids
|
